FDA
approval
· 2023-05-30
FDA Approved: VEVYE — Original Application (Harrow Eye, LLC)
Summary
FDA approved VEVYE, a cyclosporine ophthalmic solution, from Harrow Eye, LLC, through its original NDA. It is indicated for the treatment of dry eye disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VEVYE (CYCLOSPORINE OPHTHALMIC SOLUTION)